Migaba is a centrally acting medicine used in the management of neuropathic pain conditions, helping to reduce abnormal pain signals arising from damaged or dysfunctional nerves. It is indicated for the treatment of diabetic peripheral neuropathic pain, postherpetic neuralgia, and other forms of peripheral neuropathic pain. By modulating nerve excitability and decreasing excessive pain transmission within the nervous system, Migaba helps relieve burning sensations, shooting pain, tingling, and discomfort commonly associated with chronic neuropathic conditions. This medicine is widely used in long-term pain management strategies to improve functional ability, sleep quality, and overall quality of life in patients suffering from persistent nerve-related pain under medical supervision.